The University of Arizona
Home Grand Rounds Anti-TNF Drugs and Malignancy

Anti-TNF Drugs and Malignancy


April 13, 2012

 

Daniel Kreutz, MD
Fellow, Rheumatology Section
The University of Arizona Arthritis Center





Objectives 
Participant should be able to:

1. Review evidence suggesting anti-TNF drugs increase risk for malignancy
2. Review evidence suggesting anti-TNF drugs do not increase risk for malignancy
3. Discuss difficulties in finding the actual relationship between anti-TNF drugs and malignancy

 

Disclosure:

Dr. Kreutz has nothing to disclose